000275916 001__ 275916
000275916 005__ 20240918112604.0
000275916 0247_ $$2doi$$a10.1021/acsptsci.3c00013
000275916 037__ $$aDKFZ-2023-00904
000275916 082__ $$a610
000275916 1001_ $$00000-0002-3934-2468$$aSagini, Micah N.$$b0$$eFirst author
000275916 245__ $$aKhasianine Affects the Expression of Sugar-Sensitive Proteins in Pancreatic Cancer Cells, Which Are Altered in Data from the Rat Model and Patients
000275916 260__ $$aWashington, DC$$bACS Publications$$c2023
000275916 3367_ $$2DRIVER$$aarticle
000275916 3367_ $$2DataCite$$aOutput Types/Journal article
000275916 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1726651529_5616
000275916 3367_ $$2BibTeX$$aARTICLE
000275916 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000275916 3367_ $$00$$2EndNote$$aJournal Article
000275916 500__ $$a#EA:G401#LA:G401# / 2023 Apr 13;6(5):727-737 / Owen Biochemistry and Biomarkers Unit
000275916 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000275916 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000275916 7001_ $$0P:(DE-He78)c53db83479d3d1265967405af71f69bb$$aKlika, Karel D.$$b1$$udkfz
000275916 7001_ $$0P:(DE-He78)43996fb100428b0d99e233c3261f7187$$aOwen, Robert$$b2
000275916 7001_ $$0P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676$$aBerger, Martin$$b3$$eLast author
000275916 773__ $$0PERI:(DE-600)2934670-8$$a10.1021/acsptsci.3c00013$$gp. acsptsci.3c00013$$n5$$p727-737$$tACS pharmacology & translational science$$v6$$x2575-9108$$y2023
000275916 909CO $$ooai:inrepo02.dkfz.de:275916$$pVDB
000275916 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-3934-2468$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000275916 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c53db83479d3d1265967405af71f69bb$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000275916 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)43996fb100428b0d99e233c3261f7187$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000275916 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000275916 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000275916 9141_ $$y2023
000275916 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-15
000275916 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACS PHARMACOL TRANSL : 2022$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000275916 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bACS PHARMACOL TRANSL : 2022$$d2023-10-27
000275916 9202_ $$0I:(DE-He78)G401-20160331$$kG401$$lMolekulare Toxikologie und Chemotherapie$$x0
000275916 9201_ $$0I:(DE-He78)G401-20160331$$kG401$$lMolekulare Toxikologie und Chemotherapie$$x0
000275916 9201_ $$0I:(DE-He78)A390-20160331$$kA390$$lAG Wirkstoffforschung$$x1
000275916 9200_ $$0I:(DE-He78)G401-20160331$$kG401$$lMolekulare Toxikologie und Chemotherapie$$x0
000275916 980__ $$ajournal
000275916 980__ $$aVDB
000275916 980__ $$aI:(DE-He78)G401-20160331
000275916 980__ $$aI:(DE-He78)A390-20160331
000275916 980__ $$aUNRESTRICTED